1. AUTOLOGOUS STEM CELL TRANSPLANTATION AS PART OF FIRST‐LINE THERAPY IN PATIENTS WITH PERIPHERAL T‐CELL LYMPHOMA: A MULTICENTER GELTAMO/FIL STUDY. (12th June 2019) Authors: Lopez‐Parra, M.; Bellei, M.; Rambaldi, A.; Novelli, S.; Panizo, C.; Martelli, M.; Dhouly, I.; Bastos, M.; Gutierrez, A.; Sancho, J.; Ramirez, M.; Moraleda, J.; Carrillo Cruz, E.; Jimenez Ubieto, A.; Jarque, I.; Vittolo, U.; de las Heras, N.; Arranz, R.; Lopez‐Jimenez, J.; Montalbán, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AUTOLOGOUS STEM CELL TRANSPLANTATION MAY POTENTIALLY ABROGATE THE NEGATIVE PROGNOSTIC EFFECT OF EARLY RELAPSE AFTER CHEMO OR INMUNOCHEMOTHERAPY IN FOLLICULAR LYMPHOMA. (June 2017) Authors: Jiménez Ubieto, A.; Grande, C.; Caballero, D.; Yañez, L.; Novelli, S.; Hernández‐Garcia, M.; Manzanares, M.; Arranz, R.; Ferreiro, J.; Bobillo, S.; Mercadal, S.; Galego, A.; López‐Jiménez, J.; Moraleda, J.; Vallejo, C.; Albo, C.; Pérez‐Ceballos, E.; Marrero, C.; Magnano, L.; Palomera, L. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. BENDAMUSTINE AS PART OF CONDITIONING REGIMEN FOR AUTOLOGOUS STEM‐CELL TRANSPLANTATION IN PATIENTS WITH AGGRESSIVE LYMPHOMAS: FINAL ANALYSIS OF A PHASE 2 STUDY FROM GELTAMO. (June 2017) Authors: Martín, A.; Redondo, A.M.; Valcárcel, D.; González, A.P.; Suárez‐Lledó, M.; Bello, J.L.; Canales, M.; Gayoso, J.; Conde, E.; Jarque, I.; del Campo, R.; Arranz, R.; Terol, M.J.; Rifón, J.; Rodríguez, M.J.; Ramírez, M.J.; Castro, N.; Sánchez, A.; López‐Jiménez, J.; Briones, J. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Can we improve the classification of ampullary adenocarcinoma? the value of histomolecular classification and clinicopatothological features on prognosis. (2021) Authors: Muñoz, P.; Arranz, R.; Pastor, P.; Carretero, I.; Moreno, E.; Del Campo Abendea, L.; Perna, C.; Fernández-Cebrián, J.M.; Sanjuanbenito, A.; Santana, A. Journal: HPB Issue: Volume 23(2021)Supplement 3 Page Start: S755 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Coexistence of marginal zone cutaneous B‐cell lymphoma and classic Hodgkin disease: does a biological relationship exist?. (3rd April 2013) Authors: Gallo, E.; Pérez‐Gala, S.; Navarro, R.; Fraga, J.; Adrados, M.; Arranz, R.; García‐Diez, A.; Aragüés, M. Journal: Clinical and experimental dermatology Issue: Volume 38:Number 4(2013) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients. (March 2019) Authors: Rogado, J.; Sánchez-Torres, J.M.; Romero-Laorden, N.; Ballesteros, A.I.; Pacheco-Barcia, V.; Ramos-Leví, A.; Arranz, R.; Lorenzo, A.; Gullón, P.; Donnay, O.; Adrados, M.; Costas, P.; Aspa, J.; Alfranca, A.; Mondéjar, R.; Colomer, R. Journal: European journal of cancer Issue: Volume 109(2019) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. LONG‐TERM RESULTS OF THE MULTICENTER PHASE II TRIAL WITH BENDAMUSTINE AND RITUXIMAB AS FIRST LINE TREATMENT FOR PATIENTS WITH MALT LYMPHOMA (MALT‐2008‐01). (June 2017) Authors: Salar, A.; Domingo‐Domenech, E.; Panizo, C.; Nicolás, C.; Bargay, J.; Muntañola, A.; Canales, M.; Bello, J.; Sancho, J.; Tomás, J.; Rodriguez, M.; Peñalver, F.J.; Palomera, L.; Grande, C.; Sánchez‐Blanco, J.J.; Arranz, R.; Conde, E.; Garcia, M.; García, J.F.; Caballero, D. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PATIENTS WITH FOLLICULAR LYMPHOMA (FL) IN MAINTAINED COMPLETE RESPONSE (CR) AT 30 MONTHS SHOW A SURVIVAL SIMILAR TO A SEX‐ AND AGE‐MATCHED SPANISH GENERAL POPULATION. (June 2017) Authors: Magnano, L.; Alonso‐Alvarez, S.; Alcoceba, M.; Rivas‐Delgado, A.; Muntañola, A.; Andrade‐Campos, M.; Rodriguez, G.; Sancho, J.; Mercadal, S.; Salar, A.; Arranz, R.; Terol, M.; Jiménez‐Ubieto, A.; González de Villambrosía, S.; Bello, J.; López, L.; Novelli, S.; De Cabo, E.; Infante, M.; Pardal, E. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗